Pharma
Phosphagenics Licenses Diclofenac Gel for Indian Market
Phosphagenics Licenses Diclofenac Gel for Indian Market 2 November 2011, Melbourne, Australia: Melbourne drug delivery technology company, Phosphagenics Limited (ASX: POH, OTCQX: PPGNY), has licensed TPM/diclofenac, its topical non-steroidal pain formulation, to Themis Medicare Pvt Ltd of Mumbai for the Indian market. This represents Phosphagenics’ first commercial deal in India and its first licensing agreement of its diclofenac product. Under the terms of the agreement, Themis Medicare is committed to pay Phosphagenics an undisclosed up-front fee and double-digit royalty payments on sales. Themis Medicare is an Indian company that manufactures, formulates and markets...
Read MoreUsing Consumer’s Intuitive Logic to influence OTC buying behaviour
This article was written by Anil Khanna for Express Pharma as the Business Head of CubeX – Business Intelligence & Strategic Consulting Division of Sorento Healthcare Setting the context When it comes to communicating to the consumer, OTC medicines communication largely follows a uniform formula: Show the problem (in a realistic or exaggerated manner) or the consumer’s pain or agony due to the problem ?introduce the product ? show how it works (scientific method) ? then the relief ? ending with the brand benefit The end result is that, more often than not, nearly all the brand communication for most OTC medicines looks quite similar if not exactly same. This...
Read MoreInto the minds of retails chemists
This article was written by Anil Khanna for Express Pharma as the Business Head of CubeX – Business Intelligence & Strategic Consulting Division of Sorento Healthcare There has been, of late, lot of action happening in pharma retail space. All India Organisation of Chemists & Druggists (AIOCD), which virtually controls the entire pharma retail industry, is corporatising itself and becoming a legal entity. Which means it will become the largest retail chain in the world! More than 700,000 chemists are part of this body, and this organisation, through its member chemists, dictates the terms of engagement. The numbers in perspective The number of chemists,...
Read MoreParacetamol combination drugs to carry warnings
Manufacturer of paracetamol combination products will now have to print a statutory warning on the drug boxes stating ‘Taking more than the daily dose of paracetamol may cause serious liver damage or allergic reactions’. Besides, the Drug Controller General of India (DCGI) has asked the state licensing authorities not to grant fresh licenses or renewals to products with combination of paracetamol, containing more than 325 mg per tablet or capsule. The decision of limiting acetaminophen (paracetamol) comes in the wake of the US FDA issuing a similar note on January 13, 2011. “Manufacturers marketing combination products having more than 325 mg of paracetamol have...
Read More